Psoriasis is a chronic auto-immune disease affecting 1 million Canadians which presents as scaly red patches on skin. For the people affected, quick access to therapies is essential. However, it can be a challenge, especially in the presence of reimbursement barriers. In Canadian healthcare, public drug plans often have barriers such as criteria. Criteria can […]
Read More